The efficacy and safety of agomelatine, sertraline, and escitalopram for senile post-stroke depression: A randomized double-blind placebo-controlled trial
Xian-Wei Yao, Yanlan Li, Zhi-Jun Yu, Cui-Ying Mo, Hongshan Pan, Chunyang Li
Topics & Concepts
MedicineEscitalopramAgomelatineSertralineHamdPlaceboInternal medicineDepression (economics)Adverse effectStroke (engine)AntidepressantAnesthesiaSignificant differenceMacroeconomicsEngineeringEconomicsAlternative medicineHippocampusMechanical engineeringPathologyStroke Rehabilitation and RecoveryDementia and Cognitive Impairment ResearchAcute Ischemic Stroke Management